Mathematical models have a long history in epidemiological research, and as the COVID-19
pandemic progressed, research on mathematical modeling became imperative and very …

Vaccine-associated enhanced disease (VAED) is a difficult phenomenon to define and can
be confused with vaccine failure. Using studies on respiratory syncytial virus (RSV) …

Antibodies are essential molecules for diagnosis and treatment of diseases caused by
pathogens and their toxins. Antibodies were integrated in our medical repertoire against …

More than a hundred thousand dengue cases are diagnosed in India annually, and about
half of the country's population carries dengue virus-specific antibodies. Dengue propagates …

Although dengue virus (DENV) infection typically causes asymptomatic disease, DENV-
infected patients can experience severe complications. A risk factor for symptomatic disease …

Antibody-dependent enhancement (ADE) is a phenomenon in which antibodies produced in
the body after infection or vaccination may enhance subsequent viral infections in vitro and …

Heterotypic secondary dengue virus (DENV) infection is a risk factor for the development of
severe disease. To assess the contribution of the developing polyclonal humoral immune …

Despite successful vaccination efforts, the emergence of new SARS-CoV-2 variants poses
ongoing challenges to control COVID-19. Understanding humoral responses regarding …

Dengue is an arboviral disease highly endemic in Bangkok, Thailand. To characterize the
current genetic diversity of dengue virus (DENV), we recruited patients with suspected …

Infection with viruses belonging to the genus Flavivirus, such as Japanese encephalitis virus
(JEV) and dengue virus (DENV), is a worldwide health problem. Vaccines against JEV and …